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Background
Eliciting effective antibody responses are key to the design
of HIV vaccines. While the HIV envelope protein is highly
immunogenic and provokes a high-titer antibody response
during viral infection and experimental immunization, affi-
nity-matured antibodies capable of neutralizing diverse
HIV isolates are rarely elicited. While recent vaccine regi-
mens have focused on DNA, viral vector, VLP, or attenu-
ated virus vaccines, of increasing interest are improved
recombinant envelope protein immunogens. Immuniza-
tions with trimeric gp140 proteins induce higher-titer neu-
tralizing antibody responses and have structural benefits
over monomeric gp120 immunizations. Novel approaches
being taken for recombinant trimeric gp140 immunogens
include the use of consensus and multi-clade gp140 tri-
mers. A consideration for these synthetic proteins that is
key to vaccine efficacy: do these proteins structurally
represent a native trimeric envelope?
Methods
To address potential differences in the functional confor-
mation of gp140 trimers, we evaluated the conformational
characteristics of trimeric gp140 proteins from varying
HIV-1 strains as well as engineered consensus gp140s via
binding studies using surface plasmon resonance with a
panel of well-characterized monoclonal antibodies (MAbs).
Results
Consensus trimers were recognized by more monoclonal
antibodies than the primary strain gp140s, suggestive of
the benefits of engineered trimers. However, analysis
revealed a low trimer concentration that is competent to
bind the quaternary-recognizing MAb PG9. Considering
the binding to other conformational MAbs, this suggests
that while the consensus gp140s contain appropriately con-
formational monomers and are trimeric, the vast majority
of the protein is not in a proper quaternary structure.
Conclusion
These data suggest that it is important to fully assess
structural differences of immunogens even though
obvious phenotypic differences may not be present.
Taken together, these observations demonstrate the need
to evaluate immunogens in a manner that allows the
measurement of functional epitope exposure and solu-
tion conformation to assess the potential to elicit a
potent, broadly-neutralizing antibody response.
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